November 18, 2026
Health news, explained with evidence
LIVE
Preventive Services Task Force Resumes Meetings Under New Leadership Blood-Based Genetic Signature May Predict CAR T-Cell Therapy Success in Lymphoma Ultraprocessed Diets May Impact Brain Reward Systems in Younger Adults Addressing Body Image and the Reality of Gluteal Anatomy Migraine and Smoking Linked to Increased Early Stroke Risk in Women CBD Oil Found Ineffective for Managing Behavioral Issues in Youths with Intellectual Disabilities Expert Advice on Hydration Gear Sparks Debate Among Recreational Runners A Structured Approach to Beginning a Strength and Cardio Routine The Role of Daily Mobility Training in Managing Sedentary Tension New Theoretical Framework Explores Memory Formation and Dementia Preventive Services Task Force Resumes Meetings Under New Leadership Blood-Based Genetic Signature May Predict CAR T-Cell Therapy Success in Lymphoma Ultraprocessed Diets May Impact Brain Reward Systems in Younger Adults Addressing Body Image and the Reality of Gluteal Anatomy Migraine and Smoking Linked to Increased Early Stroke Risk in Women CBD Oil Found Ineffective for Managing Behavioral Issues in Youths with Intellectual Disabilities Expert Advice on Hydration Gear Sparks Debate Among Recreational Runners A Structured Approach to Beginning a Strength and Cardio Routine The Role of Daily Mobility Training in Managing Sedentary Tension New Theoretical Framework Explores Memory Formation and Dementia

Blood Test Detects Early Signs Linked to Aggressive Ovarian Cancer in Study

🥗 Nutrition 2 min read 👁 4

A new study suggests that tracking a specific RNA molecule in the bloodstream may help identify very early cellular changes associated with high-grade serous ovarian cancer.

Blood Test Detects Early Signs Linked to Aggressive Ovarian Cancer in Study🥗Nutrition

Photo: Medical Xpress

Key points

  • Tu-stroma RNA levels in blood showed potential for spotting early cell changes linked to ovarian cancer.
  • The experimental approach outperformed standard CA125 testing in distinguishing early abnormal patches from healthy tissue in the sample group.
  • Researchers stress that the findings are preliminary, and further prospective studies are needed before clinical application.

Researchers investigating high-grade serous ovarian cancer—the most common and fast-growing form of the disease, which frequently originates in the fallopian tubes—have found that very early microscopic changes may leave a detectable trace in the blood. By analyzing stored blood samples, scientists measured levels of an RNA molecule known as Tu-stroma, which is transported in microscopic packages released by cells.

Elevated levels of Tu-stroma were observed not only in patients with early cancer growing into surrounding tissue, but also in individuals with tiny, localized patches of abnormal cells confined to the fallopian tube lining, known as serous tubal intraepithelial carcinoma (Stic). In a validation group, the experimental test correctly identified Stic in approximately 92% of cases while showing no signs of it in about 98% of healthy individuals. Notably, the molecule performed better than the standard CA125 protein test at distinguishing Stic from healthy samples or benign growths.

However, experts emphasize important limitations. The study analyzed samples from patients with previously confirmed diagnoses and involved a small subset with Stic, meaning the findings remain preliminary. Applying such a test broadly to asymptomatic populations could generate false positives, leading to unnecessary follow-up procedures. Furthermore, while the test might eventually improve monitoring for individuals at high inherited risk who delay preventive surgery, a negative result currently provides no medical justification to postpone recommended operations.

What to know: Persistent abdominal bloating, pelvic pain, feeling full quickly, or increased urinary urgency can sometimes signal underlying health issues. Anyone experiencing recurring symptoms should consult a general practitioner for evaluation.

Source Medical Xpress — medicalxpress.com/news/2026-11-early-linked-ovarian-cancer-blood.html ↗

Contact the newsroom

Got a tip, a proposal or a partnership question? Write to us and we will reply shortly.